Innovasc Overview

  • Founded
  • 2007
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 5

Innovasc General Information


Developer of a drug-research platform designed to provide an alternative to stent technology. The company's drug-research platform permits minimal injury balloon angioplasty and minimal footprint tacking of blood vessel blockages, enabling patients to recover from injury faster and promote the natural healing of blood vessels.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4644 Aukai Avenue
  • Honolulu, HI 96816
  • United States
+1 (808) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovasc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 08-Aug-2012 $15M 000.00 Completed Stealth
4. Early Stage VC (Series A) 00.00 00.000 Completed Stealth
3. Early Stage VC 01-Dec-2010 00000 Completed Stealth
2. Early Stage VC 01-Dec-2009 $250K Completed Stealth
1. Early Stage VC 15-Nov-2008 $250K $250K Completed Stealth
To view Innovasc’s complete valuation and funding history, request access »

Innovasc Executive Team (3)

Name Title Board Seat Contact Info
Peter Schnieder Founder & Chief Executive Officer
Robert Giasoli Executive
To view Innovasc’s complete executive team members history, request access »

Innovasc Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
H.I.G. BioHealth Partners Venture Capital Minority 000 0000 000000 0
Quaker Partners Venture Capital Minority 000 0000 000000 0
Hawaii Angels Angel Group Minority 000 0000 000000 0
Kolohala Ventures Venture Capital Minority 000 0000 000000 0
Sennet Capital Merchant Banking Firm Minority 000 0000 000000 0
To view Innovasc’s complete investors history, request access »